Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1007/s11845-021-02565-8 http://scihub22266oqcxt.onion/10.1007/s11845-021-02565-8 33641087!7914045!33641087     free     free     free Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 231.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Ir+J+Med+Sci 2022 ; 191 (1): 59-64 Nephropedia Template TP {{tp|p=33641087|t=2022. Serum calprotectin as a novel biomarker for severity of COVID-19 disease |pdf=|usr=}}{{33641087}} gab.com Text Serum calprotectin as a novel biomarker for severity of COVID-19 disease JO: Ir J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=33641087 #FOAvip BACKGROUND: Some biomarkers have been reported to be related to the prognosis of the coronavirus disease 2019 (COVID-19). There are sparse data regarding the prognostic value of serum calprotectin in COVID-19 patients. AIMS: This study aimed to investigate the relationship between serum calprotectin level and clinical severity of COVID-19 disease in hospitalized patients. METHODS: This retrospective cross-sectional cohort study included 80 consecutive hospitalized patients with confirmed diagnosis of COVID-19. The study population was divided into two groups as patients hospitalized in the intensive care unit (ICU) and patients hospitalized but not in the ICU. The serum calprotectin levels, other laboratory, and clinical parameters were compared between groups. RESULTS: The mean age of the patients was 66.5 +/- 15.7 years. Of the patients, 42 were in the ICU and 38 were not. Serum calprotectin level and acute-phase reactants such as C-reactive protein, procalcitonin, ferritin, fibrinogen, and white blood cell were significantly higher in ICU patients than in non-ICU patients. ROC curve analysis identified that serum calprotectin level was a predictor for ICU requirement with an area under the curve of 0.641 (p = 0.031). Logistic regression analysis revealed that serum calprotectin was a significant determinant for whether or not patient required the ICU. CONCLUSIONS: These findings demonstrate that serum calprotectin level seems to be a useful biomarker that can predict the severity of COVID-19 disease. Serum calprotectin is a significant predictor of ICU requirement in patients with COVID-19. Twit Text FOAVip Serum calprotectin as a novel biomarker for severity of COVID-19 disease ????Ir J Med Sci http://www.kidney.de/pget.php?&tw=1&pmid=33641087 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33641087 #FOAvip English Wikipedia <ref>{{Cite pmid|33641087}}</ref> Serum calprotectin as a novel biomarker for severity of COVID-19 disease #MMPMID33641087 Kaya T; Yaylaci S; Nalbant A; Yildirim I; Kocayigit H; Cokluk E; Sekeroglu MR; Koroglu M; Guclu E Ir J Med Sci 2022[Feb]; 191 (1): 59-64 PMID33641087show ga BACKGROUND: Some biomarkers have been reported to be related to the prognosis of the coronavirus disease 2019 (COVID-19). There are sparse data regarding the prognostic value of serum calprotectin in COVID-19 patients. AIMS: This study aimed to investigate the relationship between serum calprotectin level and clinical severity of COVID-19 disease in hospitalized patients. METHODS: This retrospective cross-sectional cohort study included 80 consecutive hospitalized patients with confirmed diagnosis of COVID-19. The study population was divided into two groups as patients hospitalized in the intensive care unit (ICU) and patients hospitalized but not in the ICU. The serum calprotectin levels, other laboratory, and clinical parameters were compared between groups. RESULTS: The mean age of the patients was 66.5 +/- 15.7 years. Of the patients, 42 were in the ICU and 38 were not. Serum calprotectin level and acute-phase reactants such as C-reactive protein, procalcitonin, ferritin, fibrinogen, and white blood cell were significantly higher in ICU patients than in non-ICU patients. ROC curve analysis identified that serum calprotectin level was a predictor for ICU requirement with an area under the curve of 0.641 (p = 0.031). Logistic regression analysis revealed that serum calprotectin was a significant determinant for whether or not patient required the ICU. CONCLUSIONS: These findings demonstrate that serum calprotectin level seems to be a useful biomarker that can predict the severity of COVID-19 disease. Serum calprotectin is a significant predictor of ICU requirement in patients with COVID-19. |*COVID-19/diagnosis[MESH] |Aged[MESH] |Aged, 80 and over[MESH] |Biomarkers/blood[MESH] |Cross-Sectional Studies[MESH] |Humans[MESH] |Intensive Care Units[MESH] |Leukocyte L1 Antigen Complex/*blood[MESH] |Middle Aged[MESH] |Patient Acuity[MESH] |Prognosis[MESH]Serum calprotectin as a novel biomarker for severity of COVID-19 disea(epmc).pdf DeepDyve Pubget Overpricing